HIF1-IN-3?

CAS No. 333314-79-7

HIF1-IN-3?( Benzenepropanamide, N-[(8-hydroxy-7-quinolinyl)(4-methoxyphenyl)methyl]- )

Catalog No. M28955 CAS No. 333314-79-7

HIF1-IN-3 is an effective inhibitor of HIF-1 (EC50 = 0.9 μM) and can be used in anticancer studies.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 35 In Stock
5MG 58 In Stock
10MG 87 In Stock
25MG 177 In Stock
50MG 335 In Stock
100MG 460 In Stock
200MG 668 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    HIF1-IN-3?
  • Note
    Research use only, not for human use.
  • Brief Description
    HIF1-IN-3 is an effective inhibitor of HIF-1 (EC50 = 0.9 μM) and can be used in anticancer studies.
  • Description
    HIF1-IN-3 is an effective inhibitor of HIF-1 (EC50 = 0.9 μM) and can be used in anticancer studies.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Benzenepropanamide, N-[(8-hydroxy-7-quinolinyl)(4-methoxyphenyl)methyl]-
  • Pathway
    Angiogenesis
  • Target
    HIF/HIF Prolyl-hydroxylase
  • Recptor
    SIRT2
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    333314-79-7
  • Formula Weight
    412.5
  • Molecular Formula
    C26H24N2O3
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 125 mg/mL (303.04 mM)
  • SMILES
    O=C(NC(C1=CC=C2C=CC=NC2=C1O)C3=CC=C(OC)C=C3)CCC4=CC=CC=C4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Schiedel M, et al. Structure-Based Development of an Affinity Probe for Sirtuin 2. Angew Chem Int Ed Engl. 2016 Feb 5;55(6):2252-6.
molnova catalog
related products
  • 103D5R

    103D5R is a small-molecule inhibitor of HIF-1α that displays an EC50 of 35 uM against hypoxia-induced alkaline phosphatase enzymatic reporter activity.

  • IOX 2

    IOX2 is a selective inhibitor of the Hypoxia Inducible Factor (HIF) Prolyl-Hydroxylases (PHD).

  • JTZ-951

    A novel potent, orally active HIF prolyl hydroxylase (PHD) inhibitor with IC50 of 0.22 uM for PHD2.